The Pasteur 2030 strategic vision propels the Institut Pasteur into the future by addressing the most critical health challenges of our time. Focused on innovation, multidisciplinary research, and global collaboration, Pasteur 2030 aims to strengthen our scientific leadership while enhancing public health impact.
The health impacts of climate change and environmental degradation are becoming increasingly apparent. Rising temperatures, habitat disruption, and changing ecosystems create new opportunities for pathogens to thrive, leading to the emergence and re-emergence of infectious diseases. The Institut Pasteur is uniquely positioned to address these challenges through its multidisciplinary approach.
Researching mosquito- and tick-borne illnesses such as malaria, dengue, Zika, and Lyme disease, with the aim of predicting outbreaks and developing effective interventions.
Studying pathogens that arise due to environmental shifts, including their modes of transmission and potential for pandemics.
Utilizing cutting-edge technologies, including satellite data and artificial intelligence, to map and predict disease hotspots linked to environmental changes.
Integrating the study of human, animal, and environmental health to create holistic prevention and treatment strategies.
The world remains vulnerable to infectious diseases, from long-standing challenges like tuberculosis to emerging threats such as SARS-CoV-2. The Institut Pasteur is leveraging its historical leadership in microbiology and infectious diseases to combat these risks and address the growing challenge of antimicrobial resistance (AMR).
Tackling the “silent pandemic” of AMR through new drug discovery, stewardship programs, and global surveillance initiatives.
Strengthening systems to detect and respond to pandemics in collaboration with global health organizations like WHO and the Pasteur Network.
Advancing vaccine development for known and emerging pathogens, such as COVID-19 variants, Ebola, and influenza.
Developing fast, affordable diagnostic tools to identify pathogens and AMR strains.
In 2023, Pasteur scientists discovered a new class of antibiotics effective against multidrug-resistant bacteria, offering hope in the fight against AMR. Collaborative efforts also led to a regional AMR surveillance program spanning 15 countries in Africa.
The health impacts of climate change and environmental degradation are becoming increasingly apparent. Rising temperatures, habitat disruption, and changing ecosystems create new opportunities for pathogens to thrive, leading to the emergence and re-emergence of infectious diseases. The Institut Pasteur is uniquely positioned to address these challenges through its multidisciplinary approach.
By understanding the origins of disease, the Institut Pasteur aims to shift the healthcare paradigm from treatment to prevention. This knowledge will inform new therapies, personalized medicine, and policies that promote long-term health.
Investigating the rise of autoimmune diseases and how inflammation contributes to cancer, cardiovascular disease, and more.
Exploring how the trillions of microbes that live in and on our bodies influence disease development, immune function, and mental health.
Studying how genetic and environmental factors shape individual responses to infections, contributing to long-term health outcomes.
Researching how genetics, lifestyle, and environmental factors can be combined to develop individualized approaches to disease prevention and treatment
The earliest and latest stages of life are uniquely vulnerable to health challenges. From maternal and child health to aging populations, the Institut Pasteur is committed to advancing science that supports well-being throughout the lifespan.
Studying the role of the maternal microbiome during pregnancy and its influence on child development, immunity, and lifelong health.
Understanding how the immune system changes with age and identifying interventions to reduce susceptibility to infections and chronic diseases.
Developing vaccines tailored for newborns and the elderly, two groups with distinct immune needs.
Researching the biological processes of aging to promote healthier longevity, improve quality of life, and reduce the impact of age-related diseases.
Investigating the critical stages of early development to better understand how nutrition, immunity, and environmental factors influence lifelong health.
Through partnerships with the Pasteur Network, the Institut Pasteur is scaling up efforts to support maternal-child health programs in low-resource settings. This includes vaccine delivery initiatives and nutrition-focused interventions.
Health at the extremes of life sets the foundation for resilience and well-being. The Institut Pasteur’s work aims to reduce health inequities, ensuring that vulnerable populations worldwide can access the care and protection they need.
